Alliance Global Partners Weighs in on Organigram Q4 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Investment analysts at Alliance Global Partners reduced their Q4 2024 earnings per share (EPS) estimates for shares of Organigram in a report released on Monday, December 9th. Alliance Global Partners analyst A. Grey now forecasts that the company will earn ($0.03) per share for the quarter, down from their previous forecast of ($0.02). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS and FY2025 earnings at ($0.03) EPS.

Separately, Canaccord Genuity Group reduced their price objective on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research note on Monday.

Read Our Latest Research Report on Organigram

Organigram Stock Performance

Shares of OGI opened at C$2.17 on Wednesday. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13. The company has a 50-day simple moving average of C$2.29 and a 200-day simple moving average of C$2.32. Organigram has a 52-week low of C$1.61 and a 52-week high of C$3.95. The company has a market capitalization of C$235.60 million, a PE ratio of -0.86, a P/E/G ratio of 0.42 and a beta of 1.13.

Insider Activity

In other news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. Corporate insiders own 31.32% of the company’s stock.

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Recommended Stories

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.